SEC Filing Analysis: Surrozen, Inc.

Executive Summary

• Trading Significance: High
• Key Takeaway: Renowned hedge fund Millennium Management has disclosed a new 6.6% beneficial ownership stake in Surrozen, Inc., a small-cap biotech firm.
• Market Impact: This filing is a strong bullish signal, representing a significant vote of confidence from a sophisticated institutional investor in a company with a ~$110 million market capitalization.

Company Information

Field	Value
Company	Surrozen, Inc.
Ticker Symbol	Not provided in filing
CIK	0001824893
Industry	Biological Products

Insider Information

Field	Value
Name	Millennium Management LLC / Israel A. Englander
CIK	0001319244 (for Integrated Core Strategies)
Title/Position	Institutional Investor
Relationship	Beneficial Owner (>5%)

Transaction Details

Field	Value
Form Type	SCHEDULE 13G
Event Date	2025-11-13
Transaction Code	Not Applicable
Security Type	Common Stock, par value $0.0001 per share
Shares Involved	Not Applicable (Position Filing)
Price Per Share	Not Applicable
Total Value	Not Applicable
Shares Beneficially Owned	564,847
Ownership Type	Indirect

Financial Impact Assessment

Position Materiality

Metric	Value
Est. Position Value	~$7.26 Million
% of Market Cap	6.6%
Shares Owned	564,847
% of Class	6.6%
Est. Shares Outstanding	~8.56 Million (calculated from filing)
Materiality Assessment	Highly Significant

Impact Evaluation

• Market Cap Context: Surrozen is a small-cap company with a market capitalization of $110 million. A new investment stake valued at over $7 million, representing 6.6% of the company, is a substantial capital allocation and a material event for a company of this size.
• Ownership Concentration: The entry of Millennium as a 6.6% owner introduces a major institutional player to the company's shareholder base, which can lend credibility and stability.
• Transaction Significance: The disclosure of a new stake exceeding 5% by a prominent hedge fund is considered highly significant. It indicates that Millennium has conducted extensive due diligence and sees potential value or a catalyst in Surrozen. This is a passive stake, meaning the filer does not intend to influence control of the company.

Market Impact Analysis

Stock Impact Prediction

• Direction: Positive
• Reasoning: The entry of a large, well-respected institutional investor is a strong bullish signal. It validates the company's prospects to the broader market and can attract follow-on investment from other funds and retail investors.

Volume & Sentiment

• Expected Volume Impact: An increase in trading volume is likely as the market digests the news of Millennium's investment.
• Sentiment Indicator: Bullish. This news provides a strong third-party validation for the company's equity story.

Investment Insights

Positive Market Indicators

• Institutional Validation: A new 6.6% stake from a top-tier hedge fund like Millennium is a powerful endorsement.
• Increased Visibility: The filing will likely increase market awareness and analyst coverage for Surrozen.

Risk Factors

• While the filing is positive, investors should remember that small-cap biotechnology is an inherently volatile sector with clinical and regulatory risks.

Key Takeaways

1. Millennium Management has established a new, significant 6.6% stake in Surrozen, Inc.
2. The position is valued at approximately $7.26 million, a material amount relative to Surrozen's $110 million market cap.
3. This action serves as a strong bullish indicator from a sophisticated market participant, potentially leading to increased investor interest.

Additional Context

Transaction Notes

• This Schedule 13G was filed under Rule 13d-1(c), indicating a passive investment without the purpose or effect of changing or influencing the control of the issuer.
• The event that triggered the filing occurred on November 13, 2025.